Memantine Alleviates Brain Injury and Neurobehavioral Deficits after Experimental Subarachnoid Hemorrhage

Molecular Neurobiology

Volumn 51, Issue 3, 2015, Pages 1038-1052

  Huang, Chih Yuan ^a,b   Wang, Liang Chao ^a,b   Wang, Hao Kuang ^a,c   Pan, Chia Hsin ^a   Cheng, Ya Yun ^a   Shan, Yan Shen ^a,b   Chio, Chung Ching ^a,d   Tsai, Kuen Jer ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Blood brain barrier; Memantine; Neuroprotection; Nitric oxide synthase; Subarachnoid hemorrhage

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; MEMANTINE; NEUROPROTECTIVE AGENT;

ANIMAL; BRAIN INJURIES; COMPLICATION; DRUG EFFECTS; MALE; MENTAL DISORDERS; MOTOR ACTIVITY; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; SUBARACHNOID HEMORRHAGE;

ANIMALS; BRAIN INJURIES; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMANTINE; MENTAL DISORDERS; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 84939877500     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8767-9     Document Type: Article

References (48)

1. Macdonald RL, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Jaja B, Lantigua H, Le Roux P, Lo B, Louffat-Olivares A, Mayer S, Molyneux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK, Collaboration S (2013) Subarachnoid Hemorrhage International Trialists data repository (SAHIT). World Neurosurg 79(3–4):418–422
2. King JT Jr (1997) Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am 7(4):659–668
3. Cahill J, Calvert JW, Zhang JH (2006) Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26(11):1341–1353
4. Sarrafzadeh A, Haux D, Kuchler I, Lanksch WR, Unterberg AW (2004) Poor-grade aneurysmal subarachnoid hemorrhage: relationship of cerebral metabolism to outcome. J Neurosurg 100(3):400–406
5. Hillered L, Vespa PM, Hovda DA (2005) Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 22(1):3–41
6. Arundine M, Tymianski M (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34(4–5):325–337
7. Schulz MK, Wang LP, Tange M, Bjerre P (2000) Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 93(5):808–814
8. Park S, Yamaguchi M, Zhou C, Calvert JW, Tang J, Zhang JH (2004) Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 35(10):2412–2417
9. Sehba FA, Chereshnev I, Maayani S, Friedrich V Jr, Bederson JB (2004) Nitric oxide synthase in acute alteration of nitric oxide levels after subarachnoid hemorrhage. Neurosurgery 55(3):671–677, discussion 677–678
10. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 16(8):2479–2487
11. Rammes G, Danysz W, Parsons CG (2008) Pharmacodynamics of memantine: an update. Curr Neuropharmacol 6(1):55–78
12. Chen HS, Wang YF, Rayudu PV, Edgecomb P, Neill JC, Segal MM, Lipton SA, Jensen FE (1998) Neuroprotective concentrations of the N-methyl-d-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86(4):1121–1132
13. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data. Neuropharmacology 38(6):735–767
14. Ehrlich M, Knolle E, Ciovica R, Bock P, Turkof E, Grabenwoger M, Cartes-Zumelzu F, Kocher A, Pockberger H, Fang WC, Wolner E, Havel M (1999) Memantine for prevention of spinal cord injury in a rabbit model. J Thorac Cardiovasc Surg 117(2):285–291
15. Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman R, Minematsu K, Donnan GA, Howells DW (2009) Good laboratory practice: preventing introduction of bias at the bench. Stroke 40(3):e50–e52
16. Bederson JB, Germano IM, Guarino L (1995) Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 26(6):1086–1091, discussion 1091–1082
17. Thal SC, Sporer S, Klopotowski M, Thal SE, Woitzik J, Schmid-Elsaesser R, Plesnila N, Zausinger S (2009) Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats. Laboratory investigation. J Neurosurg 111(5):988–994
18. Sugawara T, Ayer R, Jadhav V, Zhang JH (2008) A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 167(2):327–334
19. Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, Lombard FW (2009) Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol 21(4):326–333
20. Silasi G, Colbourne F (2009) Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats. Behav Brain Res 198(2):380–387
21. Germano A, Caffo M, Angileri FF, Arcadi F, Newcomb-Fernandez J, Caruso G, Meli F, Pineda JA, Lewis SB, Wang KK, Bramanti P, Costa C, Hayes RL (2007) NMDA receptor antagonist felbamate reduces behavioral deficits and blood–brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma 24(4):732–744
22. Lin KY, Cherng CG, Yang FR, Lin LC, Lu RB, Yu L (2011) Memantine abolishes the formation of cocaine-induced conditioned place preference possibly via its IL-6-modulating effect in medial prefrontal cortex. Behav Brain Res 220(1):126–131
23. Quintard H, Borsotto M, Veyssiere J, Gandin C, Labbal F, Widmann C, Lazdunski M, Heurteaux C (2011) MLC901, a traditional Chinese medicine protects the brain against global ischemia. Neuropharmacology 61(4):622–631
24. Belayev L, Busto R, Zhao W, Ginsberg MD (1996) Quantitative evaluation of blood–brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739(1–2):88–96
25. Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A 86(22):9030–9033
26. Khan J, Brennand DM, Bradley N, Gao B, Bruckdorfer R, Jacobs M (1998) 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J 330(Pt 2):795–801
27. Juan WS, Lin HW, Chen YH, Chen HY, Hung YC, Tai SH, Huang SY, Chen TY, Lee EJ (2012) Optimal Percoll concentration facilitates flow cytometric analysis for annexin V/propidium iodine-stained ischemic brain tissues. Cytometry Part A 81(5):400–408
28. Westermaier T, Jauss A, Eriskat J, Kunze E, Roosen K (2009) Time-course of cerebral perfusion and tissue oxygenation in the first 6 h after experimental subarachnoid hemorrhage in rats. J Cereb Blood Flow Metab 29(4):771–779
29. Germano A, d'Avella D, Imperatore C, Caruso G, Tomasello F (2000) Time-course of blood–brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir 142(5):575–580, discussion 580–571
30. Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, Macdonald RL (2009) Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci 10:103
31. Lipton SA (2004) Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1(1):101–110
32. Zuccarello M, Lewis AI, Upputuri S, Farmer JB, Anderson DK (1994) Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits. J Neurotrauma 11(6):691–698
33. Dyker AG, Lees KR (1999) Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke. Stroke 30(9):1796–1801
34. Tribut O, Bentue-Ferrer D, Verdier MC, le groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de T (2010) Therapeutic drug monitoring of felbamate. Therapie 65(1):35–38
35. Xia P, Chen HS, Zhang D, Lipton SA (2010) Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci 30(33):11246–11250
36. Block F, Schwarz M (1996) Memantine reduces functional and morphological consequences induced by global ischemia in rats. Neurosci Lett 208(1):41–44
37. 2+ in hippocampal slices. Neuropharmacology 38(9):1253–1259
38. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ, Memantine Study G (2003) Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348(14):1333–1341
39. Wilcock G, Mobius HJ, Stoffler A, group MMM (2002) A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 17(6):297–305
40. Sabri M, Kawashima A, Ai J, Macdonald RL (2008) Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis. Brain Res 1238:163–171
41. Seif el Nasr M, Peruche B, Rossberg C, Mennel HD, Krieglstein J (1990) Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 185(1):19–24
42. 2+-dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity. J Physiol 585(Pt 3):741–758
43. Sharp CD, Houghton J, Elrod JW, Warren A, Jackson TH, Jawahar A, Nanda A, Minagar A, Alexander JS (2005) N-methyl-d-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. Am J Physiol Heart Circ Physiol 288(4):H1893–H1899
44. Scott GS, Bowman SR, Smith T, Flower RJ, Bolton C (2007) Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-d-aspartate (NMDA) receptor activation. Biochem Pharmacol 73(2):228–236
45. Gursoy-Ozdemir Y, Can A, Dalkara T (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35(6):1449–1453
46. Freeman LR, Keller JN (2012) Oxidative stress and cerebral endothelial cells: regulation of the blood–brain-barrier and antioxidant based interventions. Biochim Biophys Acta 1822(5):822–829
47. Gorgulu A, Kins T, Cobanoglu S, Unal F, Izgi NI, Yanik B, Kucuk M (2000) Reduction of edema and infarction by Memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat. Acta Neurochir 142(11):1287–1292
48. Paul C, Bolton C (2002) Modulation of blood–brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-d-aspartate receptor antagonist memantine. J Pharmacol Exp Ther 302(1):50–57